EUVIMEDEUVIMED entdecken
Open Access

TPM1 drives cytoskeleton-immunometabolism coupling and LGALS9/CD45-mediated neuroinflammatory propagation in retinitis pigmentosa

Rong Li iD, Jun-Qi Fan, Bin Lin iD

Science Advances · 29.05.2026 · 12 (22)

DOI: 10.1126/sciadv.aea6467 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 29.05.2026. Verfasst von Rong Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Optometry, The Hong Kong Polytechnic University, Hong Kong, China. Hauptthemen laut MEDLINE: Retinitis Pigmentosa, Cytoskeleton, Tropomyosin, Leukocyte Common Antigens. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: General Research Fund (GRF) from the Hong Kong Research Grants Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Retinitis pigmentosa (RP), the most prevalent inherited retinal degeneration, features progressive photoreceptor loss with no approved disease-modifying therapies. While microglia-driven neuroinflammation accelerates RP progression, its sustaining mechanisms remain elusive. Through integrated multiomics profiling of retinal degeneration 10 (rd10) mice, we identify tropomyosin 1 (TPM1) as a previously unrecognized cytoskeletal-immune regulator orchestrating spatial neuroinflammation in RP. Genetic ablation of Tpm1 attenuated microglial reactivity and preserved vision, whereas overexpression triggered self-reinforcing inflammation via four interlocked axes: (i) TPM1-mediated activator protein-1 (AP-1) hyperactivation initiates senescence-associated secretory phenotype (SASP) through mitogen-activated protein kinase (MAPK) kinase/extracellular signal–regulated kinase 3–dependent MAPK signaling; (ii) SASP subsequently mediates reduced phagocytosis; (iii) Tpm1-Apoe/Fabp5 axis disruption precipitates lipid droplet accumulation with cholesterol crystallization; (iv) galectin-9 (LGALS9)/CD45-mediated intermicroglial signaling propagates inflammatory signals across the retina. Our work redefines TPM1 as a linchpin in self-sustaining neurodegeneration cycles, where cytoskeletal dysfunction fuels immunometabolic collapse. These findings unveil precision therapeutic strategies targeting TPM1 hubs—notably the LGALS9/CD45 axis—to disrupt inflammatory cycles while preserving retinal homeostasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinitis PigmentosaCytoskeletonTropomyosinLeukocyte Common AntigensGalectinsNeuroinflammatory DiseasesAnimalsMiceMicrogliaHumansSignal TransductionDisease Models, Animal

Substanzen

TropomyosinLeukocyte Common AntigensGalectinsPtprc protein, mouse

Autor:innen und Institutionen

  • School of Optometry, The Hong Kong Polytechnic University, Hong Kong, China.
  • Research Centre for SHARP Vision (RCSV), The Hong Kong Polytechnic University, Hong Kong, China.

ORCID-Profile: Rong Li, Bin Lin

Förderung

  • General Research Fund (GRF) from the Hong Kong Research Grants Council

Zitieren

APA

Li, R., Fan, J. Q., & Lin, B. (2026). TPM1 drives cytoskeleton-immunometabolism coupling and LGALS9/CD45-mediated neuroinflammatory propagation in retinitis pigmentosa. Science Advances, 12(22). https://doi.org/10.1126/sciadv.aea6467

Vancouver

Li R, Fan JQ, Lin B. TPM1 drives cytoskeleton-immunometabolism coupling and LGALS9/CD45-mediated neuroinflammatory propagation in retinitis pigmentosa. Science Advances. 2026;12(22). doi:10.1126/sciadv.aea6467

BibTeX
@article{Li2026,
  author = {Li, Rong and Fan, Jun-Qi and Lin, Bin},
  title = {TPM1 drives cytoskeleton-immunometabolism coupling and LGALS9/CD45-mediated neuroinflammatory propagation in retinitis pigmentosa},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {22},
  doi = {10.1126/sciadv.aea6467}
}
Kostenlos starten →